How often have you heard, "I can't wait for things to go back to normal" or "this is our new norm?" What is even considered normal anymore, and is it safe to believe we will ever "get back to normal?" If past pandemics or life-changing events are any indication, things won't just go back to "normal." However, lessons will continue to be learned. Just like previous pandemics, COVID-19 will serve as a wake-up call to improve outbreak responses and keep other diseases under control, especially in the event world. To do our part in improving future responses, Innovative Global, an Innovative Group company, is now offering rapid onsite testing services to events, venues, workplaces, and schools.
PREPARING FOR THE RETURN OF LIVE EVENTS
"Once the dust has settled and the post-COVID-19 landscape becomes clearer, the need for audience engagement and face-to-face interaction will be more prevalent than ever," said Adam Parry of Event Industry News. "Sure, there will always be a need for virtual events, but can they ever really replace the buzz, creativity, and sheer vibrancy of a live event?" The true answer is no, not really; however, now more than ever, we will all be more aware of our surroundings and everybody's health and personal well being…an advantage to us all as we move forward.
Innovative Group's President, Barry Kates, recognizes this and has worked with health industry experts to make sure we are prepared now, more than ever, for when live events and programs enter the landscape once again. The Innovative Global team has helped to build the fastest, most accurate, and cost-effective testing solution available. These rapid on-site Testing Services are preparing us all and opening the pathway to live events, school, and work programs being able to exist in a safe and healthy environment.
· Built on FDA approved breakthrough technology
· Service on-location wherever you are
· Non-invasive and easy-to-administer
· Administered by a licensed medical professional
· Results within minutes
· Ability to test thousands of people per day
YOU HAVE PCR OPTIONS
Innovative Global's program offers two options based on your needs for health data and safety levels. At present, polymerase chain reaction (PCR) and antibody testing are the dominant ways that global healthcare systems are testing for COVID-19.
OPTION 1 - PCR testing for your entire community
OPTION 2 - PCR testing for high-risk individuals only
"The majority of the current COVID-19 tests that all the reports are coming from are using PCR," says University of Sussex senior lecturer in microbiology Dr. Edward Wright. "They detect the genetic information of the virus, the RNA. That's only possible if the virus is there and someone is actively infected."
PCR tests are used to directly detect an antigen's presence, rather than the presence of the body's immune response, or antibodies. By detecting viral RNA, which will be present in the body before antibodies form or symptoms of the disease are present, the tests can tell whether someone has the virus very early on.
The program offers a comprehensive screening process to identify the most at-risk individuals in your community. Everyone who participates receives a questionnaire, a thermal temperature reading, and a minimally invasive finger prick antibody test by a licensed medical professional. The sample is tested immediately at the point of care, and results are available within minutes.
COVID-19 PCR TEST
Individuals who test positive will then take a rapid PCR test to determine if the virus is active in the body. The test uses a nasal swab specimen and provides results in 90 minutes or less.
Is your event out in a field or a remote location? No problem! Innovative Group's optional mobile laboratory is engineered and constructed to meet or exceed the CDC NIH BMBL guidelines and the World Health Organization (WHO) guidelines for BSL-3 laboratories and are available as an option for clients who do not have on-site lab infrastructure.
All individuals who are tested will receive a text message confirming their results. The benefits of such a rapid on-site testing platform are:
· The Fastest And Most Accurate Solution Available
· Real-Time Results
· 100% accurate in detecting Coronavirus antibodies and 99.3% accurate in ruling them out
· Exponentially More Cost-Effective
· Early Detection
· Complete Turnkey Testing Solution
If quick-response antigen tests like these are effectively deployed across the worldwide healthcare ecosystem, they could play a crucial role in stopping the spread of COVID-19. Antibody tests will still be vital in determining any immunity that develops among the population. However, these antigen tests can be used to confirm cases of active infection without PCR's arduous process of laboratory testing.